94 related articles for article (PubMed ID: 3220039)
1. [Use of flow cytometry in hybridoma technology].
Khristov K; Bratanov M
Eksp Med Morfol; 1988; 27(3):1-6. PubMed ID: 3220039
[No Abstract] [Full Text] [Related]
2. Culture conditions that optimize outgrowth of hybridomas.
Hamilton MJ; Davis WC
Methods Mol Biol; 1995; 45():17-28. PubMed ID: 7550679
[No Abstract] [Full Text] [Related]
3. Cryopreservation of spleen and lymph nodes as a source of mononuclear cells to be used for the development of monoclonal antibody producing hybridoma cells.
Sogut I; Hatipoglu I; Serhatli M; Cevik SI; Durali D; Basalp A
Cryo Letters; 2011; 32(3):266-74. PubMed ID: 21766156
[TBL] [Abstract][Full Text] [Related]
4. Enzyme-linked immunosorbent assay and flow cytometric methods to screen hybridoma culture supernatants for antibodies to bovine neutrophil surface antigens, and monoclonal antibody production and characterization.
Salgar SK; Paape MJ; Alston-Mills B
Am J Vet Res; 1993 Sep; 54(9):1415-25. PubMed ID: 8239127
[TBL] [Abstract][Full Text] [Related]
5. Variants of an interspecies hybridoma with altered tumorigenicity and protective ability against mouse myeloma tumors.
Baumal R; Musclow E; Farkas-Himsley H; Marks A
Cancer Res; 1982 May; 42(5):1904-8. PubMed ID: 7066902
[TBL] [Abstract][Full Text] [Related]
6. Colcemid treatment of myeloma prior to cell fusion increases the yield of hybridomas between myeloma and splenocyte.
Miyahara M; Nakamura H; Hamaguchi Y
Biochem Biophys Res Commun; 1984 Nov; 124(3):903-8. PubMed ID: 6508785
[TBL] [Abstract][Full Text] [Related]
7. Cell cycle analysis by flow cytometry in an antibody secreting cell line.
Schliermann M; Beckers C; Miltenburger HG
Dev Biol Stand; 1987; 66():101-9. PubMed ID: 3582741
[TBL] [Abstract][Full Text] [Related]
8. The effect of postfusion cell density on establishment of hybridomas.
Kontseková E; Novák M; Kontsek P; Borecký L; Lesso J
Folia Biol (Praha); 1988; 34(1):18-22. PubMed ID: 3391325
[TBL] [Abstract][Full Text] [Related]
9. [Morphocytochemical and electron microscopic research on murine hybridoma cells producing and not producing monoclonal antibodies].
Sidorenko SP; Gluzman DF; Vetrova EP; Iurchenko OV; Berdova AG
Tsitologiia; 1988 Jan; 30(1):39-43. PubMed ID: 3358281
[TBL] [Abstract][Full Text] [Related]
10. Production of anti-tumor human monoclonal antibodies using different approaches.
Liu H; Xu ZL; Wang Y; Yang L; Feng O; Li Y; Wang YM; Zhang GG
Hum Antibodies Hybridomas; 1993 Jan; 4(1):2-8. PubMed ID: 8381684
[TBL] [Abstract][Full Text] [Related]
11. [Comparative characteristics of some parameters of the cell nucleus in the series myeloma-hybridoma-lymphocyte].
Sokolova IA; Volgin AIu; Smirnova TD; Lupga IP; Khodarev NN; Shishkin SS
Biokhimiia; 1993 Mar; 58(3):357-66. PubMed ID: 8485224
[TBL] [Abstract][Full Text] [Related]
12. Transfection of NS0 myeloma fusion partner cells with HSP70 gene results in higher hybridoma yield by improving cellular resistance to apoptosis.
Lasunskaia EB; Fridlianskaia II; Darieva ZA; da Silva MS; Kanashiro MM; Margulis BA
Biotechnol Bioeng; 2003 Feb; 81(4):496-504. PubMed ID: 12491534
[TBL] [Abstract][Full Text] [Related]
13. [Monoclonal antibodies from the hybridization of lymphocytes].
Ax W
Ric Clin Lab; 1983; 13 Suppl 2():1-9. PubMed ID: 6366991
[No Abstract] [Full Text] [Related]
14. Flow cytometry analysis of the neutralization effect of anti-IL-8 McAbs on IL-8-activated human granulocytes.
Ji YY; Ye GQ
Shi Yan Sheng Wu Xue Bao; 1995 Sep; 28(3):257-61. PubMed ID: 8571708
[TBL] [Abstract][Full Text] [Related]
15. [Establishment of hybridoma secreting anti-mycobacteria monoclonal antibody by using electrofusion technique].
Guo M; Pan Z; Wang H
Wei Sheng Wu Xue Bao; 1998 Oct; 38(5):393-5. PubMed ID: 12549406
[TBL] [Abstract][Full Text] [Related]
16. Use of I region-restricted, antigen-specific T cell hybridomas to produce idiotypically specific anti-receptor antibodies.
White J; Haskins KM; Marrack P; Kappler J
J Immunol; 1983 Mar; 130(3):1033-7. PubMed ID: 6185566
[TBL] [Abstract][Full Text] [Related]
17. Hybridoma technology.
Price PJ
Ric Clin Lab; 1984; 14(3):277-86. PubMed ID: 6395287
[No Abstract] [Full Text] [Related]
18. Preparation of human-mouse heterohybridomas against an immunising antigen.
Jessup CF; Baxendale H; Goldblatt D; Zola H
J Immunol Methods; 2000 Dec; 246(1-2):187-202. PubMed ID: 11121559
[TBL] [Abstract][Full Text] [Related]
19. [Current developments in hybridoma technology].
Osterhaus AD; UytdeHaag AG
Tijdschr Diergeneeskd; 1985 Oct; 110(20):835-9. PubMed ID: 3878011
[TBL] [Abstract][Full Text] [Related]
20. The hybridoma technology: I. Production of monoclonal antibodies.
Epstein N; Epstein M
Adv Biotechnol Processes; 1986; 6():179-218. PubMed ID: 3535831
[No Abstract] [Full Text] [Related]
[Next] [New Search]
